Anti-CD20 monoclonal antibodies in primary progressive multiple sclerosis: a real-life comparative study of rituximab vs. ocrelizumab C. Alcala, C. Quintanilla-Bordas, F. Gascon-Gimenez,A. P. Sempere,L. Navarro, M. Carcelen-Gadea, A. Belenguer,L. Landete, J. Mallada, E. Canizares, S. Carratala,L. Cubas, S. Gil-Perotin,J. A. Dominguez,F. Perez-Miralles,J. Castillo,B. CasanovaMULTIPLE SCLEROSIS JOURNAL（2021）引用 0|浏览1暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
